Zepbound (Tirzepatide) 4 doses - Médetone

Zepbound (Tirzepatidas) 4 dozės

€999,00

Weight management for high BMI

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Kas įskaičiuota į kainą?

Įeina medicininė konsultacija ir receptas, jei tai klinikiniais atvejais tinkama, o jūsų gydymas išduodamas ir pristatomas tiesiai į namus. Teikiami nuolatiniai klinikiniai stebėjimai ir patikros, siekiant palaikyti gydymą ir stebėti pažangą.

Garantijos

Tą pačią dieną išsiunčiame patvirtintus užsakymus
Diskretiškas, konfidencialus pristatymas
Ekspertų klinikinės konsultacijos
Atsakingas klientų aptarnavimas

Reikalingas galiojantis asmens tapatybės dokumentas

Prieš išrašant receptą ir išduodant šį vaistą, būtina patvirtinti tapatybę. Užsakymo pateikimo metu būsite paprašyti pateikti galiojantį asmens dokumentą. Priimami asmens dokumentai yra nacionalinis asmens tapatybės kortelė, pasas arba vairuotojo pažymėjimas.

Stiprumas: 2.5 mg

2.5 mg
5 mg
7.5 mg
10 mg
12.5 mg
15 mg

Produkto variantai

Our customers say Excellent Rated 4.7 Trustpilot Trustpilot

Zepbound Tirzepatide Weight Loss Injections

Greita santrauka

Vaistų rūšis

Dual GIP and GLP-1 receptor agonist.

Veikia pagal

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Veiklioji medžiaga

Tirzepatide

Veiksminga per

Within a few weeks.

Generinis?

No

Šalutinis poveikis

Nausea, vomiting, diarrhea, decreased hunger, stomach pain, and constipation.

How it works

Clinician-led care, designed to be simple from start to finish.

1

Step 1

Check eligibility

Answer a short 2-minute questionnaire so we can understand your goals and medical history.

2

Step 2

Doctor approval

If eligible, one of our doctors issues your free prescription within 24 hours.

3

Step 3

Fast delivery, ongoing support

Next-day delivery across the EU, with support at every step of your treatment.

Vaistų informacija

Aprašymas

Zepbound (tirzepatidas) yra kartą per savaitę po oda vartojamas GLP-1 receptorių agonistas ir GIP receptorių agonistas, skirtas lėtiniam svorio valdymui suaugusiems, turintiems nutukimą (KMI ≥ 30 kg/m²) arba antsvorį (KMI ≥ 27 kg/m²) su bent viena su svoriu susijusia gretutine liga, tokia kaip hipertenzija, 2 tipo cukrinis diabetas ar dislipidemija. Klinikiniai duomenys rodo efektyvumą mažinant kūno svorį ir gerinant kardiometabolinius rodiklius, kai jis derinamas su gyvenimo būdo pokyčiais, įskaitant kalorijų apribojimą ir padidintą fizinį aktyvumą. Zepbound parodė galimą naudą mažinant miego apnėjos ir hipopnėjos indekso sunkumą pacientams, sergantiems vidutinio ir sunkaus laipsnio obstrukcine miego apnėja ir tuo pačiu turintiems nutukimą. Kontraindikacijos – kartu vartojant kitus tirzepatido turinčius preparatus arba GLP-1 receptorių agonistus. Pediatrinis saugumas ir veiksmingumas nėra nustatyti. Gydymą turėtų pradėti ir stebėti kvalifikuotas sveikatos priežiūros specialistas. Šis produktas skirtas tik pagal receptą.

Naudojimo instrukcija

To use Zepbound effectively, start with the prescribed dose, injecting once a week on the same day. Administer injections in the abdomen, thigh, or upper arm, rotating sites to avoid irritation. Before injecting, clean your hands and the injection area. Let refrigerated medication warm slightly for comfort. Use clean techniques for needle attachment and injection, disposing of sharps properly. Store the medication in the fridge or briefly at room temperature as allowed. If a dose is missed, take it soon if within a few days; otherwise, skip it and never double dose. Regularly consult with your healthcare provider to adjust doses and discuss any side effects. Always follow your healthcare provider's detailed instructions.

Ingredientai

Tirzepatide, the active substance in Zepbound, works by mimicking the actions of natural hormones in the body that regulate blood sugar and appetite. As a dual GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-like Peptide-1) receptor agonist, it enhances insulin secretion in response to high blood sugar levels, slows down gastric emptying, and reduces appetite and food intake, leading to improved glycemic control and weight loss in adults with type 2 diabetes mellitus.

Šalutinis poveikis

Gastrointestinal issues (nausea, vomiting, diarrhea, constipation), potential hypoglycemia (especially when used with other diabetes medications), injection site reactions, and possibly others depending on the individual's health condition and other medications being taken.

Įspėjimai

When using Zepbound (tirzepatide), important precautions include being vigilant for severe abdominal pain indicative of pancreatitis, monitoring blood sugar levels due to the risk of hypoglycemia when combined with other diabetes medications, reporting any changes in urination that could signal kidney issues, and seeking immediate medical attention for persistent digestive problems like vomiting or diarrhea. It's also crucial to inform your doctor of any personal or family history of thyroid cancer, given studies in rodents linking Zepbound-like medications to thyroid issues. Be alert for signs of allergic reactions, and if you're pregnant or breastfeeding, consult with your healthcare provider about potential risks.

Jūsų istorijos, mūsų pasididžiavimas

Dažniausiai užduodami klausimai

How quickly does Zepbound start to work?

The onset of Zepbound's effects can vary, but patients may begin to see improvements in their blood sugar levels and weight within a few weeks of starting treatment. Continuous use in conjunction with diet and exercise enhances its efficacy.

Do I need a prescription for Zepbound?

Yes, Zepbound is a prescription medication. You will need to consult a healthcare provider to determine if it's appropriate for your condition and to receive a prescription. Using our online consultation service will enable you to answer a short questionnaire that would be used by one of our clinical prescribers to determine your eligibility for the treatment and approve or decline and refund your order.

How is Zepbound administered?

Zepbound is administered as a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the site of injection rotated each week to minimise the risk of skin irritation.

How should Zepbound be stored?

Zepbound should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen in its original packaging to protect from light. Once in use, it may be kept at room temperature for 30 days.

What is the difference between Wegovy and Zepbound?

Wegovy and Zepbound are both injectable medications used primarily for weight management in adults, but they differ in their active ingredients and mechanisms of action.

Wegovy:

Active Ingredient: Semaglutide.
Mechanism of Action: Wegovy functions as a GLP-1 receptor agonist, mimicking the action of the glucagon-like peptide-1 hormone which regulates appetite and calorie intake. It enhances feelings of fullness and reduces hunger, leading to a reduction in food intake.
Usage: Approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.

Zepbound:

Active Ingredient: Tirzepatide.
Mechanism of Action: Zepbound is unique in that it acts as both a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. This dual action not only helps in reducing appetite and food intake like GLP-1 agonists but also enhances insulin secretion in a glucose-dependent manner and possibly affects fat metabolism.
Usage: Initially approved for the treatment of type 2 diabetes, with promising results in significant weight reduction, leading to its approval for use in obesity management as well.

While both medications are part of a broader category of drugs used for metabolic management, the dual mechanism of Zepbound may offer broader metabolic effects compared to Wegovy. Both have shown effectiveness in weight loss and improvements in various metabolic parameters in clinical trials, but the choice between them may depend on individual health profiles, specific medical conditions, and healthcare provider recommendations.

Patikrinkite tinkamumą